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Abstract
BPAG1a and BPAG1b (BPAG1a/b) constitute two major isoforms encoded by the dystonin (Dst) gene and show homology
with MACF1a and MACF1b. These proteins are members of the plakin family, giant multi-modular proteins able to connect
the intermediate filament, microtubule and microfilament cytoskeletal networks with each other and to distinct cell
membrane sites. They also serve as scaffolds for signaling proteins that modulate cytoskeletal dynamics. To gain better
insights into the functions of BPAG1a/b, we further characterized their C-terminal region important for their interaction with
microtubules and assessed the role of these isoforms in the cytoskeletal organization of C2.7 myoblast cells. Our results
show that alternative splicing does not only occur at the 59 end of Dst and Macf1 pre-mRNAs, as previously reported, but
also at their 39 end, resulting in expression of additional four mRNA variants of BPAG1 and MACF1. These isoform-specific C-
tails were able to bundle microtubules and bound to both EB1 and EB3, two microtubule plus end proteins. In the C2.7 cell
line, knockdown of BPAG1a/b had no major effect on the organization of the microtubule and microfilament networks, but
negatively affected endocytosis and maintenance of the Golgi apparatus structure, which became dispersed. Finally,
knockdown of BPAG1a/b caused a specific decrease in the directness of cell migration, but did not impair initial cell
adhesion. These data provide novel insights into the complexity of alternative splicing of Dst pre-mRNAs and into the role of
BPAG1a/b in vesicular transport, Golgi apparatus structure as well as in migration in C2.7 myoblasts.
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Introduction
Bullous pemphigoid antigen 1 (BPAG1), encoded by the
dystonin gene (Dst), is a member of the plakin family of cytolinkers.
This protein family connects the intermediate filament (IF),
microtubule (MT) and microfilament (MF) cytoskeletal networks
with each other and to distinct cell membrane sites and act as
scaffolds and adaptors for signaling proteins that modulate
cytoskeletal dynamics, cell migration, differentiation, and stress
responses [1–3].
Multiple transcription initiation sites and alternative splicing of
Dst results in three major BPAG1 isoforms, BPAG1a (,600 kDa),
BPAG1b (,800 kDa), and BPAG1e (,300 kDa), which exhibit
different tissue-specific expression profiles and functions. Further-
more, at least three alternative transcription start sites give rise to
several Dst mRNA variants encoding different N-terminal
BPAG1a/b isoforms [4]. While BPAG1e is found in stratified
epithelia, BPAG1a and b are predominantly expressed in neurons
and in striated muscles, respectively [4,5]. BPAG1a/b are
homologous to the mammalian microtubule actin cross-linking
factor 1 (MACF1) isoforms a and b (MACF1a/b) [6], and to
Drosophila Short stop (Shot) [7]. MACF1a and Shot are important
for MT network structure maintenance [8,9]. Shot, BPAG1a/b
and MACF1a/b differ from the other plakins by having a unique
rod domain that consists of spectrin repeats (SRs), in addition to
the SRs that make up the common plakin domain. These proteins
are therefore also called spectraplakins [1].
The BPAG1a/b isoforms are made up of multiple modular
domains. They possess an actin-binding domain (ABD) and a
plakin domain in their N-terminus, and an MT-binding domain
(MTBD) in their C-terminus (Fig. 1). The latter is composed of a
growth arrest-specific protein 2 related (GAR) domain, which
binds to and stabilizes MTs and a glycine-serine-arginine (GSR)
repeat-containing region, which bundles MTs [10]. In addition,
the C-terminal extremity of BPAG1a/b is able to form a complex
with end-binding protein 1 (EB1) [11]. EB1 is a core component of
the MT plus end complexes, which autonomously tracks MT plus
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ends and recruits other proteins. Furthermore, BPAG1a is a
binding partner of p150Glued subunit of dynactin [12], which also
interacts with MT plus end proteins. Dynactin is thought to
mediate the binding of dynein to cargos such as membranous
organelles [13]. Interestingly, BPAG1a is also a binding partner of
endocytic vesicle proteins called transmembrane protein 108 (or
retrolinkin) and clathrin [14,15].
The importance of the various BPAG1 isoforms is best attested
by the dramatic consequences observed in cases of genetic defects
of BPAG1. Naturally occurring mutations as well as engineered
inactivation of Dst in mice cause dystonia musculorum (dt), a
disease characterized by sensory and motor neuron degeneration,
and early death [16–18]. In humans, a pathogenic mutation
affecting the MTBD of BPAG1a/b results in sensory autonomic
neuropathy with dysautonomia, severe psychomotor retardation,
and early death [19], while disruption of BPAG1a/b due to a
chromosome breakpoint in the middle of one of the DST gene
copies, is associated with encephalopathy, motor and mental
retardation, and visual impairment [20]. Dst-null mice showed
also discrete signs of skin blistering as a result of an impaired
attachment of keratin IFs to hemidesmosomes in basal keratino-
cytes due to the absence of BPAG1e [21]. In humans, by analogy,
homozygous nonsense DST mutations affecting BPAG1e result in
epidermolysis bullosa simplex with fragility of basal keratinocytes
and skin blistering [22,23].
In skeletal muscle and cardiac tissues, BPAG1b is found
colocalized with Z-discs, intercalated discs, and sarcolemma, but
not with myosin and, surprisingly, actin [24,25]. Furthermore, dt
mice exhibit an intrinsic muscle weakness, increased muscle
fatigability and sarcolemmal fragility, and an altered myotube
cytoarchitecture [26], suggesting that BPAG1b has important roles
in muscles.
In this study we sought to gain better insight into the complexity
of BPAG1 isoforms and their role in MT organization and
stabilization in the mouse myoblast cell line C2.7. We have
identified novel mouse BPAG1a/b (and MACF1a/b) isoforms due
to alternative splicing of the 39 end of their pre-mRNA affecting
the C-tail of the proteins. By using siRNA-mediated Dst silencing,
we further characterized the impact of BPAG1 isoforms on MT
stability, cytoskeletal organization, cell migration, vesicular trans-
port and cell adhesion of C2.7 myoblasts.
Results and Discussion
Novel variants of BPAG1a and/or b and MACF1a and/or b
and their tissue expression profile
Three different transcription initiation sites can result in the
expression of three BPAG1a and/or b isoforms with different N-
terminal sequences. These variations either precede the ABD in
isoforms 1 and 2, or change the structure of the ABD in isoform 3,
affecting the actin-binding activity of the proteins [4,27–29]. By
analogy with the N-terminus, we investigated the existence of
different isoforms with various C-terminal sequences that interact
with MTs. By using the 39 genomic region of the mouse Dst gene
to perform a BLAST search in the mouse expressed sequence tag
(EST) database, we found several EST clones. Comparison of
these ESTs to the reported cDNA sequences of BPAG1a/b
revealed one additional unreported sequence (exon termed b) in
between the third and second to the last exon of each gene as well
as the alternative use of an upstream exon (exon a) (Fig. S1). Two
major isoforms of MACF1, a and b, have sequences similar to
those of BPAG1a/b. Alternative splicing at the 39 end of Macf1
pre-mRNAs similar to that of Dst was also found (Fig. S1).
Therefore, alternative splicing potentially yields four C-terminal
BPAG1a and/or b (and MACF1a and/or b) isoforms termed,
nBPAG1, aBPAG1, bBPAG1, and abBPAG1 (with ‘‘n’’ denoting
the absence of amino acid stretches encoded by exons a and b)
(Fig. 2 and S2A).
To determine if the EST sequences were indeed part of the
coding regions of Dst and Macf1 genes, we performed RT-PCR
studies using mouse brain and heart RNAs. Primers were designed
for the already documented and newly discovered 39 ends (listed in
Table S1). The sequences of the amplified cDNA fragments were
identical to those predicted for the novel variants. Next, we
performed RT-PCR using variant-specific primers against total
RNA isolated from different mouse organs (Fig. 3). The results
Figure 1. Schematic representation of BPAG1a and b domain organization. ABD, actin-binding domain; CH, calponin homology domain;
SR, spectrin repeat (dotted ovals represent putative SRs, not previously identified as SRs [63], or predicted in mouse or human BPAG1a sequence by
SMART [64]; some SRs in the plakin domain were deduced from the alignment with plectin plakin domain [65], SH3, src homology-3 domain (is
atypical and embedded in SR5 [66]); PRD, plakin repeat domain; EFhs, EF hands; GAR, GAS2-related domain; GSRs, Gly-Ser-Arg repeats; EBBS, EB1/EB3-
binding site containing a Ser-X-Ile-Pro motif (where is X is any residue); MTBD, microtubule-binding domain. BPAG1a (NP_598594) is 5379 res. long.
BPAG1b-specific domain (2014 res. long, deduced from NP_604443; 7393 res.) is inserted in between SR10 and SR11 of BPAG1a (after res. 1548).
doi:10.1371/journal.pone.0107535.g001
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showed that most variants are ubiquitously expressed, except for
aMACF1 mRNA, which is only detected in brain and lung.
Nevertheless, we observed some variant-specific differences in the
expression profile. Specifically, we did not detect the expression of
nBPAG1 in embryonic tissue in contrast to all the other BPAG1
variants, whereas aBPAG1 is absent from the liver.
All the different BPAG1a/b C-terminal isoforms can
bundle MTs and interact with EB1 and EB3
The MTBD is composed of a GAR domain that co-localizes
with and stabilizes MTs and a GSR-repeat domain that is able to
bundle MTs in transfected COS-7 cells [10]. The alternative
splicing described above affects sequences within the C-tail of
BPAG1a/b in between the GAR domain and the GSR repeats
(Fig. 2). Overexpression of all BPAG1 C-tail constructs induced
MT bundling in transfected COS-7 cells (Fig. S2B). Similar results
were also obtained for MACF1 C-tail constructs (Fig. S2C),
indicating that the bundling activity of the GSR-repeat region is
not significantly affected by flanking sequences.
Previous studies showed that by means of sequences containing
two SxIP motifs the invertebrate spectraplakin Shot is able to
recruit EB1 and adenomatous polyposis coli (APC) as well as to
promote MT assembly at the muscle-tendon junction and in
neurons [9,30]. Positively charged residues in Shot C-tail also
contribute to its interaction with EB1 and act as an MT stabilizer
[9]. BPAG1a/b and MACF1a/b contain a single SxIP motif in
their C-tail (Fig. 2). This motif is important for their interaction
with the C-terminal end of EB1 [11,31–33] (for a review, see [34]).
BPAG1b was previously shown to co-localize with GFP-EB3 in
HFFF2 fibroblasts [35]. EB3 is a neuronally expressed EB family
member which is also upregulated in muscle cells upon
differentiation [36]. We found that glutathione-agarose beads
charged with GST-EB3-C could pull down all FLAG-tagged
BPAG1-C-tail isoforms (Fig. S3) or nMACF1-C-T (data not
shown) from transfected COS-7 cell extracts. Similar results were
obtained with GST-EB1-C (data not shown). Our results thus
indicate that various C-terminal BPAG1a/b isoforms are able to
Figure 2. Protein sequence alignment of the C-terminus of BPAG1a/b and MACF1a/b. Identical amino acids are shaded in black with white
letters. Conserved amino acids changes are shaded in grey. The GAR domain, sequences encoded by the alternatively spliced exons a and b, GSR
repeats and EB1-binding site (EB1-BS) are indicated. The denomination «C-tail» corresponds to the sequence(s) after the GAR domain.
doi:10.1371/journal.pone.0107535.g002
Figure 3. Expression profile of BPAG1a/b and MACF1a/b 39-
variants in various mouse tissues. RT-PCRs were performed with
primers specific to the various plakin variants or to GAPDH from total
RNA. The amplicons were analyzed on agarose gel and stained with
ethidium bromide.
doi:10.1371/journal.pone.0107535.g003
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form a complex with the two end-binding family members, EB1 or
EB3. Knockdown of EB1 or EB3 prevents elongation and fusion of
myoblasts into myotubes [36,37]. Since BPAG1a/b interact with
both EB1 and EB3, it is plausible that BPAG1a/b are effectors of
their biological functions.
BPAG1a/b show a complex staining pattern in C2.7
myoblasts
Since in the above studies, we were unable to identify a
functional difference among the new BPAG1a/b isoforms, we next
investigated the role of BPAG1a/b in myoblasts using the C2.7
myoblast cell line, in which both BPAG1b and, less abundantly,
BPAG1a isoforms are expressed [24,26]. All isoforms were
knocked down using two distinct siRNAs targeting sequences
within the plakin domain of BPAG1 (here referred to as BPAG1
siRNA1 and siRNA3, respectively). Efficiencies of siRNA-mediat-
ed knockdown were quantified by immunoblotting (Fig. S4A).
Using both BPAG1 siRNAs, we observed an approximately 90%
knockdown efficiency in several independent experiments as
assessed at 24 h and 48 h after transfection (Fig. S4B). We verified
the specificity of the immunofluorescence signal obtained using the
rabbit antiserum R18024 directed against BPAG1a/b in C2.7
myoblasts after siRNA-mediated silencing of all known BPAG1
isoforms. In non-transfected C2.7 myoblasts or those transfected
with control siRNA, the R18024 antiserum showed a staining
pattern characterized by cytoplasmic bright dots and filamentous
structures of various lengths. The bright dots were usually
asymmetrically distributed in the cytoplasm, in perinuclear
locations as well as at the cell periphery (Fig. 4 and Fig. S4C).
The short filamentous pattern was especially well appreciated in
large lamellipodia (Fig. S4C, arrowheads). These staining patterns
were almost completely absent in cells treated with either BPAG1
siRNA1 (Fig. S4C) or siRNA3, confirming the specificity of the
signals obtained using the antiserum R18024.
Pseudopodia are implicated in myoblast adhesion and fusion
with neighboring skeletal muscle cells [38]. When we examined
BPAG1a/b pattern in confluent C2.7 cells, long thin protrusions
corresponding to pseudopodia were observed (Fig. 5, arrowheads).
These structures, which contained actin but lacked MTs at their
tips, displayed a peculiar intense BPAG1a/b staining (Fig. 5).
Since there were additional sites close to the cell membrane of
C2.7 cells showing high BPAG1a/b staining intensity (Fig. 5,
arrows), which were reminiscent of nascent pseudopodia, it is
conceivable that BPAG1a/b play a role in the formation and
function of pseudopodia in mononucleated skeletal muscle cells.
BPAG1a/b filaments mainly co-distribute with MTs
In double immunofluorescence microscopy studies of C2.7
myoblasts, BPAG1a/b showed a short filamentous staining, which
partly overlapped with EB1. The latter displayed a characteristic
comet-like staining (Fig. 4A) [37]. Interestingly, we observed that
the region with the brightest EB1 signal at MT ends lacked
BPAG1a/b signal, while a short stretch of co-localization was only
noted in the tail of the EB1 comets (Fig. 4A, insets). The observed
staining pattern was thus similar to that of Shot and DmEB1, the
Drosophila orthologs of BPAG1/MACF1 and EB1, respectively
[11]. When b-tubulin was co-stained, BPAG1a/b was found to
localize along the MT lattice (Fig. 4B, insets). The polarized dot-
like staining pattern of BPAG1a/b was most intense in areas
where the MT signal was the weakest (Fig. 4B). Since BPAG1a/b
filamentous structures did not invariably co-localize with all EB1
comet tails, BPAG1a/b likely associate only with a subset of the
growing MTs. In transfected cells expressing FLAG-tagged, full-
length BPAG1a, we observed short filament-like pattern and no
asymmetric dot-like pattern. A truncated form of the protein that
lacks all domains after the last spectrin repeat (FLAG-ABD-SR41)
displayed a dot-like pattern homogenously spread throughout the
cytoplasm (Fig. S5A and B). These observations indicate that the
co-distribution of BPAG1a, and probably BPAG1b, with the MT
network is affected by sequences contained in its C-terminal
region.
Since BPAG1a/b have an ABD at the N-terminus [4], we next
analyzed the relation of BPAG1a/b with the actin cytoskeleton. In
most cells (Fig. 4C), there was no obvious co-localization between
BPAG1a/b and actin stress fibers stained with phalloidin,
although some short filamentous structures of BPAG1a/b were
found co-aligned with actin fibers within large lamellipodia of
some C2.7 cells (arrows in Fig. 4C). These results suggest that
BPAG1a/b predominantly associate with the MTs but under
certain conditions or according to their subcellular location are
able to co-distribute with the actin cytoskeleton. Previous studies
have shown that intramolecular interaction between ABD and
MTBD of Shot prevents its interaction with actin [39]. A similar
mechanism may thus also affect the topogenic fate of BPAG1a/b.
In line with our findings, Young et al. observed a strong
perinuclear staining in C2C12 myoblasts using an antiserum
directed against a peptide sequence specific to the N-terminal
portion of the BPAG1a2/b2 isoforms [29]. These data imply that
BPAG1a2/b2 specifically contribute to the perinuclear staining
that we observed in C2.7 myoblasts using R18024 antiserum. In
contrast to our data, Young et al. also described co-localization of
BPAG1a2/b2 with actin stress fibers in the cell center of 5-10% of
C2C12 myoblasts as well as a nuclear staining of BPAG1a2/b2 in
all cells [29]. Since the R18024 antiserum used in our study binds
to the SR region and should hence recognize all N-terminal
isoforms of BPAG1a/b [40], the reasons for these staining
differences remain unclear. Finally, in contrast to MACF1a [8],
which co-localizes with focal adhesions (FAs) in keratinocytes,
BPAG1a/b did not co-localize with vinculin in FAs of C2.7 cells
(Fig. S6A).
Integrity of MT network is important for the filamentous
pattern of BPAG1a/b
To analyze the impact of MTs on the subcellular distribution of
BPAG1a/b, C2.7 myoblasts were treated with either nocodazole,
an MT-depolymerizing drug, or taxol, an MT-stabilizing drug.
Using two different nocodazole concentrations (10 mM and
0.3 mM), the MT network was either completely or partially
disrupted. In the latter case, the MTs were very short and curled.
In both tested conditions, the short filament-like pattern of
BPAG1a/b disappeared, consistent with the idea that the
filamentous staining pattern of BPAG1a/b is dependent on intact
MTs. In contrast, the polarized dot-like staining pattern persisted
upon nocodazole treatment (Fig. 6). Since the latter dot-like
pattern was also found in cells not treated with nocodazole,
particularly in areas where the MT staining signal was the weakest
(Fig. 4B), it is very likely that this is a pool of BPAG1a/b, which is
not associated with MTs.
Taxol but not DMSO treatment of C2.7 cell resulted in the
disappearance of the comet-like staining pattern of EB1, usually
leaving only faint and delicate filamentous structures as described
before [41]. In contrast, BPAG1a/b pattern generally appeared
unaffected, although some cells displayed a pattern of somewhat
longer BPAG1a/b filaments. Finally, EB1 overlap with BPAG1a/
b increased, especially in areas of high BPAG1a/b density,
suggesting that EB1 interacts more strongly with BPAG1a/b when
MTs are stabilized (data not shown).
BPAG1 in Myoblasts
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BPAG1a/b are not essential for the cytoskeleton
organization of MTs and actin stress fibers
Shot is important for the stability of MTs in neuronal axons. In
the axons of Shot-null mutant neurons, nocodazole treatment
results in extensive areas devoid of MTs, which are not observed in
wild-type neurons [9]. MACF1a is also implicated in MT
organization in neurons [42]. Based on these findings, Shot,
MACF1a, and other spectraplakins are thought to be functionally
related to MT-associated proteins (MAPs), acting as MT-
stabilizing factors [9]. By analogy, we next assessed the organi-
zation of the MT network and EB1 pattern in BPAG1-knockdown
cells, but were unable to detect any significant change by
immunofluorescence microscopy (data not shown). Furthermore,
when C2.7 cells were subjected to cold-induced MT depolymer-
Figure 4. Localization of BPAG1a/b in C2.7 myoblasts. Fixed cells were costained with anti-BPAG1a/b serum R18024 (green) and A) anti-EB1
antibody, B) anti-b-tubulin antibody, or C) TRITC-phalloidin (all in red). Blue: nuclei stained with DAPI. Scale bar: 20 mm. BPAG1a/b have a dot-like and
short-filament-like pattern. Short filaments of BPAG1a/b co-localize with EB1 comets (see A9), microtubules (see B9), and locally co-align with actin
fibers (white arrows). Note in panel B the opposite intracellular abundance of BPAG1a/b versus MTs. White frames indicate areas magnified in A9 and
B9.
doi:10.1371/journal.pone.0107535.g004
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isation, the MT network seemed to be affected to a similar extent
in both control and BPAG1 knockdown C2.7 cells as analysed by
immunofluorescence studies as well as by immunoblotting of the
soluble and insoluble MT fractions (data not shown). Finally, as
assessed by immunofluorescence, there was no difference in the
depolymerisation of the MT network between control and BPAG1
knockdown C2.7 cells upon treatment with 0.3 mM and 10 mM
nocodazole nor in the repolymerization of MTs after washing out
nocodazole (10 mM, data not shown). Our findings are in line with
previous studies showing that knockdown of BPAG1 in HFFF2
fibroblasts does not lead to any major change in the dynamics or
organization of MTs [35]. Since myoblasts and fibroblasts are
structurally similar, and fibroblast conversion to myogenic cells has
been reported [43], it is very unlikely that BPAG1a/b serve as MT
stabilizing proteins in these cell types.
Finally, by immunofluorescence analysis, we examined the
staining pattern of the actin network in BPAG1-knockdown
myoblasts using phalloidin. When compared to control cells,
BPAG1 knockdown had no impact on the MF network in
transfected cells (data not shown). Therefore, BPAG1a/b do not
seem essential for either the stability of MTs or the organization of
MT and MF networks in C2.7 myoblasts.
BPAG1a/b and vesicular transport
BPAG1a directly interacts with several vesicle-associated
proteins such as dynactin components, transmembrane protein
108, and clathrin [12,14,15]. In neuronal cells, BPAG1a was
found to co-localize with vesicles along MTs [12]. We thus
analysed FITC-dextran uptake by control and BPAG1-knock-
down C2.7 cells using immunofluorescence microscopy. Three
independent experiments consistently showed an average reduc-
tion of 20% of the dextran signal intensity in BPAG1-knockdown
cells (Fig. 7). This observation argues for some perturbation in the
endocytic pathway responsible for either a lower dextran uptake
and/or an increased recycling of the dextran-containing vesicles
back to the plasma membrane.
To dissect potential mechanisms responsible for these latter
results, we analysed the relation of BPAG1a/b with both early and
late endosomal markers by expressing GFP-tagged Rab5 and
Rab7, respectively. Immunofluorescence microscopy analysis in
C2.7 myoblasts revealed no obvious co-localization between
BPAG1a/b and either Rab5 or Rab7. Furthermore, BPAG1
knockdown did not alter the staining pattern of Rab5 and Rab7
(data not shown), an observation implying that BPAG1a/b are
associated with a different and less abundant type of vesicles. The
latter may explain why BPAG1 knockdown resulted in only a
moderate decrease of the dextran signal in C2.7 cells.
In a recent study, BPAG1 has been shown to interact and to co-
localize with herpes simplex virus (HSV) capsids in HFFF2
fibroblasts. Furthermore, inactivation of BPAG1 in these cells
negatively affected the movement of HSV capsids in anterograde
and retrograde manner [35,44]. In combination with our data,
these results suggest that BPAG1 is involved in cargo transport
along the MTs rather than in maintenance of MT structure and
organization in these cells.
Figure 5. BPAG1a/b is enriched in pseudopodia and small areas at the plasmamembrane. C2.7 cells were grown to high confluency, fixed
in PFA, and stained with anti-BPAG1a/b (green) and A) anti-b-tubulin (red) antibodies or B) TRITC-phalloidin (red). Blue: nuclei stained with DAPI. Scale
bar: 20 mm. Arrows indicate strong BPAG1a/b signals close to the plasma membrane and arrowheads BPAG1a/b localization in pseudopodia.
doi:10.1371/journal.pone.0107535.g005
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BPAG1a/b role in maintenance of Golgi apparatus
structure
BPAG1 knockout in primary neurons and knockdown in HEK
293T cells results in an increased dispersal of the Golgi apparatus
[45]. We therefore analysed Golgi structure in C2.7 myoblasts
using GM130, a marker of the cis-Golgi. As assessed by
immunofluorescence, BPAG1 knockdown also led to an increased
Golgi dispersal in C2.7 cells (Fig. 8). The Golgi dispersal induced
by BPAG1 knockdown was not increased by pre-treatment of the
cells with brefeldin A to induce complete disassembly of Golgi,
followed by a washout (data not shown). Since no obvious co-
localization between BPAG1a/b and GM130 was found, the effect
of BPAG1 on the Golgi apparatus structure is probably indirect,
although the presence of a minor fraction of BPAG1a/b associated
Figure 6. BPAG1a/b short filament pattern disappears upon microtubule depolymerization, but not the dotted pattern in C2.7
myoblasts. Cells were treated for 10 min with A) 0.32 mM or B) 10 mM nocodazole, then immediately fixed in PFA and immunolabeled with anti-b-
tubulin and anti-BPAG1a/b antibodies. Blue: nuclei stained with DAPI. Scale bar: 20 mm. C) Negative control cells were treated with a corresponding
volume of DMSO for 30 min, and processed for microscopy the same way. DMSO had no effect on the cells and BPAG1a/b pattern looked the same as
in non-treated cells (Fig. 4B).
doi:10.1371/journal.pone.0107535.g006
Figure 7. BPAG1 knockdown leads to a reduction in dextran uptake and/or retention within the C2.7 myoblasts. A) Sparsely seeded
cells were incubated with FITC-dextran (green) for 10 min and then chased for 1 h. Afterward cells were fixed in PFA, stained with DAPI (blue), and
mounted. Scale bar: 20 mm. B) Graph represents quantification of FITC signal that was measured using ImageJ for each individual cell (84–104 cells/
condition). CTCF (corrected total cell fluorescence) = Integrated Density – (Area of selected cell6Mean fluorescence of background readings). Data
are mean 6 SEM, *p = 0.03 (n = 3 independent experiments).
doi:10.1371/journal.pone.0107535.g007
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with the Golgi cannot be excluded. Please note that figure 8A also
demonstrates BPAG1 knockdown efficiency by siRNA3 and sites
of high BPAG1a/b staining intensity close to the cell membrane.
The increased Golgi dispersal observed in BPAG1-knockdown
neurons has been related to the ability of BPAG1 to associate with
MAP1B by means of its plakin domain [15]. The latter was
reported to be required for MAP1B recruitment to centrosomes.
MAP1B promotes acetylation and stabilization of MTs, which is
important for maintenance of the Golgi structure at the
centrosome [45]. The Golgi apparatus is also dependent on
dynein and dynactin for its localization at the centrosome [46,47].
To assess whether the plakin domain and its binding to MAP1B is
critical for the effect of BPAG1a/b on Golgi structure, we
expressed in C2.7 cells two BPAG1a/b recombinant proteins
encompassing the spectrin repeat 21 (SR21) through the GAR
domain fused to mCherry (mCherry-SR21-GAR) and SR21
through SR41 (mCherry-SR21-SR41, Fig. S5A). Both of these
recombinant proteins contain sequences shown to bind to
p150Glued [12], but lack the plakin domain. In contrast to what
was observed in BPAG1-knockdown C2.7 cells, the Golgi showed
a more compact structure in around 70 % of transfected cells
expressing mCherry-BPAG1a/b fusion constructs when compared
to cells transfected with the control mCherry construct (37 %) or
non-transfected cells (18 %) (Fig. S7). A similar trend was observed
in C2.7 cells transfected with FLAG-tagged, full length BPAG1a
and FLAG-ABD-SR41 in comparison to FLAG-PRD2. However,
since only few transfected cells expressed these two large
BPAG1a/b recombinants, no statistical analysis was possible.
Figure 8. Knockdown of BPAG1a/b in C2.7 cells induces the dispersal of the Golgi apparatus. A) Cells treated with control and BPAG1
siRNA were fixed in PFA and immunolabeled with anti-GM130 (cis-Golgi marker, green) and anti-BPAG1a/b (red) antibodies. Blue: nuclei stained with
DAPI. Scale bar: 20 mm. Arrows: examples of dispersed Golgi. B) Graph represents percentage of cells (200 cells per siRNA) with dispersed Golgi. Data
are mean 6 SEM, n = 3 independent experiments.
doi:10.1371/journal.pone.0107535.g008
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Our results indicate that sequences contained within the SRs of
BPAG1a/b are responsible for the regulation of the Golgi
structure by BPAG1a/b and suggest that these effects are
mediated via its interaction with p150Glued.
BPAG1 plays a role in directional C2.7 myoblast migration
Both BPAG1e and MACF1a are important for cell adhesion
and migration [8,21,48]. These processes are relevant for skeletal
muscle repair and regeneration, since myoblasts need to migrate
towards damaged myotubes, adhere to and fuse with them [49].
Vesicular transport, which is affected by BPAG1a/b as observed
in this study, is another important process for cell migration [50].
Therefore, to test the role of BPAG1a/b in myoblast migration, we
carried out a wound healing assay in BPAG1-knockdown C2.7
cells. In three independent experiments, BPAG1-knockdown C2.7
cells showed an average 27% (siRNA1) and 34.3% (siRNA3) lower
wound invasion compared to control siRNA-treated cells (Fig. 9).
To further investigate the migration defect of BPAG1-knock-
down myoblasts, we used time-lapse microscopy to track migrating
cells. This technique allowed us to focus on a specific region of the
wound and to quantify the number of cells that migrate into the
wound more accurately (Fig. 10A). Three independent experi-
ments revealed an approximately 50% reduction in the number of
cells that migrated into the wound (Fig. 10C). By cell tracking, we
found a 36% reduction in cell velocity and 29% reduction in
directness of cell migration (Fig. 10B and C). Cell counting
revealed no significant differences in cell proliferation or death rate
after knockdown of BPAG1 in C2.7 cells (data not shown),
allowing an 19 h time course for the wound closure experiments.
In line with our findings, primary myoblasts from dt mice were
also found to have a normal proliferative potential [51].
In this context, we examined the BPAG1a/b staining pattern in
migrating C2.7 cells at the wound edge, which were fixed 7 h after
scratching. By immunolabeling with the R18024 antiserum, the
most intense staining of BPAG1a/b was almost invariably
observed in the trailing portion of migrating cells, which displayed
a dotted and short filament-like pattern (Fig. S8). A similar
polarized pattern of BPAG1a/b was also observed in myoblasts
under sub-confluent conditions (Fig. 4 and Fig. S4C). Although
the mechanisms responsible for this peculiar polarized distribution
of BPAG1a/b remain to be dissected, our observations suggest
that BPAG1a/b either exert a specific function in the trailing edge
or change their subcellular redistribution secondary to post-
translational modifications of MTs [52].
Time lapse microscopy studies with sparsely seeded C2.7 cells
on cell culture plastic dishes indicated that BPAG1 knockdown
reduced migration directness but did not impair the velocity of cell
migration in these conditions (Fig. S9). Since the Golgi apparatus
influences polarized vesicular trafficking and MT orientation
toward the leading edge of the cell, its integrity is important for
directional cell migration [53–56]. Therefore, it is very likely that
decreased directness of migration of C2.7 myoblasts is the result of
the increased Golgi dispersal observed in BPAG1-knockdown
C2.7 cells (Fig. 8).
Cell-substratum adhesion is important for cell migration.
Therefore, we tested the ability of BPAG1-knockdown C2.7 cells
to adhere to plastic cell culture dishes, which were either non-
coated or coated with collagen [36]. When compared to control
cells, the number of knockdown cells that adhered to the coverslips
in both tested conditions was similar (Fig. S6B and C). Since
BPAG1a/b was not found to co-localize with vinculin in FAs,
while the staining pattern and density of FAs were similar between
control and BPAG1-knockdown C2.7 cells (Fig. S6A), a contribu-
tion of BPAG1 to initial myoblast adhesion seems very unlikely.
MACF1 deficiency impairs the migration of keratinocytes by
reducing the targeting of MTs along F-actin to FAs and by
stabilizing FA-actin networks. An intrinsic actin-regulated ATPase
in MACF1 has been reported for these biological functions
[8,21,48]. Despite their similar protein sequences, MACF1a/b
and BPAG1a/b do not seem to have the same function.
Conclusions
Our study reveals that alternative splicing of two exons coding
for the C-tail results in four additional variants of BPAG1a/b,
which are expressed in various mouse tissues. These isoforms can
all bundle MTs and interact with the MT plus end proteins EB1
and EB3. Our results show that the filamentous pattern of
BPAG1a/b in C2.7 myoblasts is due to its association with MTs,
whereas the reason for the dot-like pattern remains unclear.
Knockdown studies in C2.7 myoblasts show that BPAG1a/b have
no effect on the organization of the MT and MF networks, but
Figure 9. BPAG1 knockdown reduces C2.7 myoblast wound invasion in a wound healing assay. A) Pictures of denuded areas in C2.7 cell
layer were taken immediately after the scratch was applied (0 h) and 19 h later. Images are representative of three independent experiments. Scale
bar: 50 mm. B) Graph represents quantification of wound areas reinvaded by cells by subtracting wound area at 19 h from wound area at 0 h. Results
were expressed in comparison to myoblasts transfected with control siRNA. Data are mean 6 SEM. *p,0.05 versus control, Student’s t test, n = 3
independent experiments, 3 crosses per triplicate for each siRNA.
doi:10.1371/journal.pone.0107535.g009
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Figure 10. BPAG1 knockdown reduces the number of myoblasts migrating into a wound, myoblast migration velocity and
directness in a wound healing assay. A) The fields of view at 0 h (red) and at 18 h (green) after scratch were overlaid to visualize the invading
cells. Cell-free area at 0 h was colored in black to increase contrast on the overlay. Scale bar: 100 mm. B) Time lapse photographs were taken of
control and BPAG1 knockdown myoblasts every 10 min for 18 h. The migratory paths of individual cells that did not divide during 18 h are shown
from one of the three experiments from the lower wound edge (see panel A). C) Quantitative comparison of the number of cells transfected with
BPAG1 siRNA that had migrated into an acellular area with control siRNA transfected cells. The mean cell velocities were measured by manual
tracking using ImageJ and pooled from three independent experiments. The mean velocity of BPAG1 knockdown cells is reduced by 36 %. Cell
migration directness was quantified by calculating Euclidian distance divided by the accumulated distance for each individual cell (120 cells per
siRNA). Data are mean 6 SEM. *p,0.05 vs control, Student’s t-test, n = 3 independent experiments.
doi:10.1371/journal.pone.0107535.g010
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rather affect endocytosis and the Golgi apparatus structure. The
latter is either dispersed upon knockdown of BPAG1 or more
compact upon overexpression of BPAG1a/b SR regions that can
bind p150Glued. Finally, knockdown of BPAG1 does not impair cell
adhesion, but results in decreased directness of cell migration, for
which Golgi dispersal may be responsible. Collectively, these
results provide further insights into the complex functions of
BPAG1a/b in the membrane-bound organelle transport along
MTs, in maintenance of the Golgi apparatus structure as well as in
migration of C2.7 myoblasts.
Materials and Methods
RT-PCR
Equal amounts of total RNA extracted from various mouse
tissues (Clontech) were subject to one step RT-PCR (Qiagen). The
primers used are listed in Table S1.
Plasmid construction
The mouse aBPAG1a and MACF1a protein sequences
GeneBank accession No: NP_598594 and NP_001186066 respec-
tively were taken as references for labeling residue number. For
cloning of the C-Tail of BPAG1 and MACF1 PCR was performed
on mouse (BALB/c) brain QUICK-Clone cDNA (Clontech) using
Advantage cDNA PCR kit (Clontech) with the primers listed in
Table S1. Cycling parameters were set according to the
manufacturer’s protocol. PCR products were cloned into
pCR2.1-TOPO vector (Invitrogen). cDNA clones were sequenced.
The corresponding pTOPO clones described above were digested
with EcoR1/EcoRV and cloned into pcDNA3.1-FLAG vector
[57]. The FLAG-tagged constructs prepared for this study were
the following: nBPAG1-C-tail (res. 5157–5355), a (res. 5157–
5379), b (res. 5157–5392), and ab (res. 5157–5416) (see Fig. S1).
For cloning full length aBPAG1a cDNA, two overlapping
aBPAG1a cDNA fragments were amplified from mouse brain
cDNA library, cloned into pCR3.1-TOPO-BluntII (Invitrogen)
and sequenced. The two complementary pieces were joined
together thanks to the unique AvrII site in aBPAG1a sequence.
CMV-FLAG sequence from pcDNA3.1-FLAG was cloned in
frame with aBPAG1a coding sequence (res. 2 to 5379). This final
vector was called pTCF (for TOPO vector, CMV promoter, and
FLAG tag). pCTF-ABD-SR41 codes for FLAG-BPAG1a res. 2–
4953. Mouse BPAG1b PRD2 cDNA fragment, coding for res.
1549 to 2206 (GeneBank accession No: NP_604443), was cloned
into pcDNA3.1-FLAG. Two BPAG1a fragments were cloned into
pmCherry-C (Clontech) to obtain the mCherry fusion recombi-
nant proteins: mCherry-SR21-GAR (res. 2669–5263) and
mCherry-SR21-SR41 (res. 2669–4953) (see Fig. S5A). Constructs
encoding GFP-Rab5 and GFP-Rab7 were described elsewhere
[58,59].
Antibodies
The following primary antibodies were used rabbit antiserum
R18024 and R18611 [40], rabbit anti-skeletal myosin heavy chain
IgG (Santa Cruz Biotechnology), mouse anti-EB1 (BD Bioscienc-
es), -b-tubulin (Thermo Scientific), -vinculin (VII-F9, [60]), -
GM130 (BD biosciences), -FLAG-M2 antibody (Sigma-Aldrich),
and rat anti-FLAG tag (Stratagene). Secondary antibodies used for
immunofluorescence studies were highly cross-absorbed Alexa
Fluor 488 and 568 anti-rabbit IgG, Alexa Fluor 488 and 568 anti-
mouse, and Alexa Fluor 488 anti-rat, all from Invitrogen. For
western blotting secondary antibodies were IR-Dye 800cw anti-
rabbit IgG (LI-COR) and anti-mouse Alexa 680 (Invitrogen).
Cell culture and transient transfections
COS-7 cells were grown and transfected as previously described
[10]. C2.7 mouse myoblast cell line [61] was cultured in DMEM
(Invitrogen) supplemented to 20% with newborn calf serum (NCS,
Sigma-Aldrich), 100 U/ml penicillin and 10 mg/ml streptomycin
(PS, Sigma-Aldrich) for proliferation, and in DMEM with 4%
NCS and PS for differentiation at 37uC in 5% CO2 atmosphere.
Chemical stocks were dissolved in DMSO according to the
manufacturers’ recommendations. Cells were treated with noco-
dazole (Sigma-Aldrich) and taxol (paclitaxel, Sigma-Aldrich) at
10 mM for 10 min. One day before transfection, C2.7 cells were
seeded on glass coverslips at 2.56104 cells/cm2. C2.7 cells were
transfected using Lipofectamine 2000 (Invitrogen) for most
constructs. For large constructs, namely full-length FLAG-
aBPAG1a and FLAG-ABD-SR41, TransIT (Mirus) and X-
tremeGene HP (Roche) transfection reagents were used according
to the providers’ instructions.
Immunofluorescence
Cells grown on glass coverslips were either fixed in ice-cold
methanol at 220uC for 10 min or in 4% paraformaldehyde (PFA)
in phosphate-buffered saline (PBS) for 15 min at room tempera-
ture. Afterward, the methanol-fixed cells were air-dried and
rehydrated in PBS. PFA-fixed cells were permeabilized with 0.1%
Triton X-100 in PBS for 3 min. Coverslips were blocked with 1%
bovine serum albumin in PBS (B-PBS) for 15 min at room
temperature. Cells were labelled with primary antibodies diluted
in B-PBS for 2 h, washed 3 times in B-PBS for 5 min each time,
and then, incubated with secondary antibodies and TRITC-
phalloidin or Alexa Fluor 488-phalloidin (Invitrogen) dissolved in
B-PBS for 1 h. Then, the cells were washed one more time in B-
PBS, 2 times in PBS, and incubated with DAPI nuclear stain for
5 min. Finally, the cells were mounted in fluorescent mounting
medium (Dako). Fluorescence microscopy was performed using
Eclipse 80i microscope (Nikon).
Production of Glutathione-S-Transferase (GST) fusion
proteins
Plasmids encoding mouse GST-EB1 (res. 1–268) and GST-
EB1-C (res. 164–268) were a generous gift from Dr. Gregg
Gundersen (Columbia University). Mouse EB3 and EB3-C
sequences coding for res. 1–281 and 145–281, respectively were
amplified from mouse brain cDNA by PCR using the primers
listed in Table S1. Escherichia coli BL21 (DE3) strain was
transformed with the GST-fusion constructs as well as pGEX-2T
(empty vector) and recombinant protein expression was induced
by IPTG according to standard methods. BL21 cells were then
lysed by sonication in 20 mM Tris-HCl pH 7.5 containing 0.15 M
NaCl, 1 mM EDTA, 1 mM PMSF, 10 mg/ml pepstatin, 10 mg/
ml aprotinin, and 2 mg/ml leupeptin. Sarkosyl was added to
lysates to a final concentration of 1.5%, and the lysates were gently
mixed for 15 min. After centrifugation, supernatants were
adjusted to 2% Triton X-100 and 1 mM CaCl2, and the GST-
fusion proteins were charged on glutathione-agarose (Sigma-
Aldrich). The beads were thoroughly washed with an excess of
binding buffer.
GST pull-down assay
COS-7 cells were transfected with FLAG-tagged: n, a, b,
abBPAG1-C-Tail, n, a, and abMACF1-C-tail. After 48 h cells
were lysed in ice-cold PBS containing 1% Triton X-100 and and
1% complete protease inhibitor cocktail (Roche). Soluble cell
lysates were collected after centrifugation at 16,0006g for 10
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minutes at 4uC and incubated with glutathione-agarose beads
charged with GST-EB1, GST-EB1-C, GST-EB3, GST-EB3-C or
GST for 2 h. The beads were collected, washed extensively and
boiled in SDS loading buffer. Proteins were detected by SDS/
PAGE and western blotting with anti-FLAG antibodies.
BPAG1a/b knockdown
To knock down BPAG1, FlexiTube siRNAMm_Dst_1 (BPAG1
siRNA1) or Mm_Dst_3 (BPAG1 siRNA3) (cat. # SI00984375 and
SI00984389, Qiagen) was used. Control siRNA was from
Microsynth (cat. # 1491991). C2.7 cells were transfected using
Lipofectamine RNAiMAX (Invitrogen). For a 10 cm2 dish, 3 ml
RNAiMAX and 1 ml siRNA (10 mM) were mixed in 500 ml
DMEM and incubated at room temperature for 20 min. C2.7 cells
were trypsinized and resuspended in proliferation medium without
antibiotics (100 ml medium per 2.56105 cells). Cells and siRNA
complexes were mixed, incubated for 5 min at room temperature,
seeded at 2.56104 cells/cm2 and cultured in proliferation medium
without antibiotics for 24 h.
Preparation of cell lysates and Western blot analysis
COS-7 cell cultures were washed with phosphate buffered saline
(PBS) and scraped in lysis buffer, consisting of ice-cold PBS
containing 1% Triton X-100 and complete protease inhibitor
cocktail (Roche). Soluble cell lysates were collected after centri-
fugation at 16,0006g for 10 minutes at 4uC. Proteins were
separated by SDS–polyacrylamide gel electrophoresis (SDS–
PAGE) and transferred onto Immobilon membrane (Millipore)
using BioRad equipment. The blocked membrane was stepwise
incubated with monoclonal FLAG-M2 antibody (Sigma-Aldrich)
(1:1,000) and with goat-anti-mouse IgG-Alexa Fluor 680 conjugate
(1:5,000 Invitrogen). For detection of BPAG1a/b by Western
blotting, C2.7 cells were cultured in a 6-well plate for 24 h after
being treated with siRNA as above. Cells were rinsed in PBS two
times, lysed in buffer containing 62.5 mM Tris-HCl pH 6.8, 2.5%
SDS, and 10% glycerol (100 ml/well of a 6-well plate) and scraped
from the wells immediately. Then, the samples were heated for
3 min at 93uC and passed through 30 G syringe 3–5 times to
reduce their viscosity due to DNA. 10 ml of the sample were used
to determine protein concentration using DC protein assay
(BioRad) according to provider’s instruction. 150 mg of each
sample were mixed with necessary amount of b-mercaptoethanol
and bromophenol blue to bring to 5% and 0.002% final
concentration respectively, and heated again as above. The
proteins were separated in a 6% polyacrylamide SDS gel by
electrophoresis at 100 V until the 175 kDa protein marker band
(New England BioLabs) was at the bottom of the gel. The proteins
were electrotransferred for 75 min at 100 V in precooled buffer
with 25 mM Tris, 192 mM glycine, 0.1% SDS and 10% ethanol
to nitrocellulose membrane (Carl Roth GmbH). The membrane
was blocked in PBS with 0.1% Tween-20 (PBS-T) and 5%
skimmed milk (M), incubated for 2 h with primary antibodies
dissolved in PBS-T-M, washed 3 times in PBS-T-M, and
incubated for 1 h with secondary antibodies dissolved in PBS-M.
Finally, the membrane was rinsed once in PBS-M and twice in
PBS. Protein bands were visualized and their intensity quantified
using Odyssey infrared imaging system (LI-COR).
Cell migration assay
Cells treated with control and BPAG1 siRNA 24 h before were
trypsinized and seeded at 5% confluency into a 6-well dish pre-
incubated overnight with proliferation medium because it contains
vitronectin. This also made conditions more similar to the wound
healing assay. The left-over cells were seeded on glass coverslips
for control of knockdown efficiency by immunofluorescence. Cells
in the 6-well dish were allowed to attach for 2 h and then switched
to DMEM with 10 mg/ml of freshly dissolved mitomycin C
(Applichem) for 3 h to inhibit cell division. Then, cells were
switched to proliferation medium and imaged using BioStation
CT (Nikon). Phase contrast images were taken every 10 min for
19 h with 4x lens at 3 different positions in each well. Velocity and
directness of cell migration were measured by manual tracking and
chemotaxis and migration plugin (Ibidi) in ImageJ.
Wound healing assay
Cells were treated with control and BPAG1 siRNA for 24 h as
above and cultured in a 12-well dish. Either one scratch per well or
3 parallel scratches and 1 scratch perpendicular to them to make 3
intersections (crosses) were applied to the cell monolayers using a
200 ml pipette tip. The medium was immediately changed to fresh
proliferation medium to remove the detached cells. Then, a phase
contrast picture was taken of each scratch cross immediately and
19 h later using Eclipse TE-2000-4 microscope (Nikon). Wound
areas were measured using ImageJ. For time lapse microscopy,
cells with one scratch per well were switched to fresh proliferation
medium with 25 mM HEPES and placed under the Eclipse TE-
2000-4 microscope equipped with a 37uC chamber, recording an
image of the scratch every 10 min for 19 h. Velocity and
directness of cell migration were measured by manual tracking
and chemotaxis and migration plugin (Ibidi) in ImageJ.
Ice-induced microtubule depolymerization assay
Protocol was mostly as described before [62]. Cells were
switched to 4uC growth medium with 25 mM HEPES and
incubated on ice for 0, 0.5, 1, 2, 4, 6 and 19 h. Vessels with ice and
cells were kept at 4uC for all incubation times. Then, the cells
grown on glass cover slips were permeabilized in BRB80 (80 mM
PIPES pH 6.8, 1 mM MgCl2, 4 mM EGTA, 0.5% Triton X-100
for 30 sec prior to fixation and immunofluorescence analysis. The
cells cultured in 6-well plates without cover slips were lysed in MT
stabilization buffer (20 mM Tris, pH 6.8, 2 mM EGTA, 1 mM
MgCl2, 0,5% NP-40, 140 mM NaCl, and 4.7 mM taxol) for 20 .
Cells were scraped from the wells, transferred to 1.5 ml tubes, and
centrifuged at 20,0006g. The supernatant (tubulin fraction) was
transferred to fresh tubes. The pellets (MT fraction) were
resuspended in 1x SDS sample buffer with 6 M Urea in 1/4th
of the corresponding supernatant volume. Dissolved pellets were
passed through 30 G syringe 3–5 times. 18.75 ml of each lysate
(mixed with 6.25 ml 4x SDS sample buffer and heated at 95uC for
5 min) and 18.75 ml of dissolved pellet (not heated) samples
processed for western blotting and densitometric analysis using
Odyssey system (LI-COR).
Dextran uptake assay
C2.7 cells were transfected with siRNA and seeded at a density
of 1.256104 cells/cm2 on glass cover slips. 24 h later, the cover
slips were either placed into PFA for KD control by immunoflu-
orescence later, or transferred to a humidified, light-impermeable
chamber. These cells were pulsed for 10 min with 5 mg/ml FITC-
dextran (MW 10,000, Sigma-Aldrich) in pre-warmed proliferation
medium. Then, the cells were quickly rinsed 3 times in warm
proliferation medium, and chased for 1 h in the same medium.
Finally, the cells were quickly washed in PBS once, fixed, stained
with DAPI, and mounted.
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Cell adhesion
Procedure was mostly as described before [36]. C2.7 cells were
transfected with siRNA as above and grown in proliferation
medium for 24–48 h. Afterward, cells were trypsinized, counted,
and seeded at 1000 cells/well into a 12-well dish coated with
50 mg/ml collagen (Invitrogen) in 0.02 M acetic acid overnight at
4uC, or at 35,000 cells/well into a non-coated 12-well cell culture
dish pre-incubated with proliferation medium. Cells were allowed
to attach for 70 min. Then, the unattached cells were washed
away by rinsing the wells once with PBS. The attached cells were
fixed in PFA, and stained with Giemsa solution (Sigma-Aldrich).
The number of cells per mm2 was determined by overlaying a grid
with 0.16 mm2 squares under the wells and counting the total
number of cells attached.
Supporting Information
Figure S1 Genomic organization of the Dst andMacf1 39
exons. The alternatively spliced exons are labeled a and b. The
translated sequences are in blue, red, and grey.
(TIF)
Figure S2 Recombinant BPAG1a/b-C-Tail isoforms and
MACF1a/b-C-Tail isoforms bundle MTs in transiently
transfected COS-7 cells. A) Schematic representation of
FLAG-tagged BPAG1a/b-C-Tail (T) proteins expressed in
transfected COS-7 cells. The amino acid numbers, corresponding
to the first residue encoded by each of the last four exons, as well as
the C-terminal residue of BPAG1a, are indicated (see also Fig. 2).
B) Cells expressing the indicated FLAG-BPAG1a/b-C-T isoforms
were double labeled with polyclonal anti-FLAG antibody (A, D,
G, J) and monoclonal anti-tubulin antibody (B, E, H, K).
Ectopically expressed proteins showed a predominant nuclear
staining and induced bundling of MTs even though co-localization
of the different BPAG1a/b-C-T isoforms with bundled MTs was
not systematically observed. C) same as B) for the indicated FLAG-
MACF1a/b-C-T isoforms corresponding to the respective FLAG-
BPAG1a/b-C-T isoforms (see Fig. 2 for MACF1a/b exon
borders).
(TIF)
Figure S3 BPAG1-C-T interacts with EB3 in GST pull-
down assays. COS-7 cells were transfected with different
FLAG-tagged BPAG1-C-T constructs and their lysates were used
in GST pull-down assays with GST, GST-EB3 (res. 1-281), or -
EB3-C (res. 145-281) as indicated. The presence of FLAG-
BPAG1-C-T associated with the glutathione-Sepharose beads was
detected by Western blotting with an anti-FLAG antibody. GST-
APC-C did not pull down FLAG-nBPAG1-C-T (data not shown).
(TIF)
Figure S4 BPAG1a/b can be efficiently knocked down in
C2.7 myoblasts. A) Western blot analysis of BPAG1a/b and
myosin heavy chain (MHC) levels in cells transfected with control
(Ctrl) siRNA or BPAG1 siRNA1 or siRNA3. BPAG1a/b was
detected with anti-serum R18611 and MHC was detected
sequentially on the same blot. Results are representative of three
independent experiments for 24 h after transfection and two for
48 h after transfection for BPAG1 siRNA1 and siRNA3. B)
Quantification of BPAG1a/b knockdown by normalization to
MHC. Data are mean 6 SD. C) Cells treated with control siRNA
or BPAG1 siRNA1 for 24 h were fixed in PFA and immunola-
beled with anti-BPAG1a/b serum R18024. Scale bar: 20 mm.
BPAG1a/b have a dot-like (arrows) and short-filament-like
(arrowheads) pattern. The same results were obtained for cells
treated with siRNA3 (data not shown, see also Fig. 8). D) The
three types of BPAG1a/b pattern were quantified in cells not
treated by siRNA (NT), treated with control siRNA, BPAG1
siRNA1 or siRNA3 (n= 204–235 cells/condition).
(TIF)
Figure S5 FLAG-BPAG1a and FLAG-ABD-SR41 display
strikingly different patterns. A) BPAG1a constructs used to
transfect C2.7 cells. The borders of the FLAG- and mCherry-
tagged recombinant proteins are indicated by black lines under the
scheme of aBPAG1a. B) Cells were transfected with the indicated
constructs, fixed in PFA, and immunolabeled with anti-FLAG
antibody. Scale bar: 10 mm.
(TIF)
Figure S6 BPAG1a/b are not co-localized with FAs and
do not affect FAs or C2.7 cell-substratum adhesion. A)
Control and BPAG1 knockdown C2.7 cells were cultured for 24 h
on uncoated glass cover slips and processed for immunofluores-
cence observation. No significant differences in pattern of vinculin,
a focal adhesion marker, were noted between the two cell groups.
Adhesion assay was performed seeding cells into B) non-coated or
C) collagen-coated 12-well dishes, respectively. Data are mean 6
SEM. Student’s t-test, n = 3 independent experiments.
(TIF)
Figure S7 Expression of BPAG1a fragments containing
p150Glued interaction region leads to higher Golgi
compactness in C2.7 myoblasts. A) and B) Cells were
transfected with the indicated constructs (see Fig. S5A), fixed in
PFA, and immunolabeled with anti-GM130 antibodies. Scale bar:
20 mm. The arrows indicate transfected cells with typical Golgi
compaction. White frames indicate areas magnified in A9 and B9.
Note the unexpected diffuse pattern of mCherry-SR21-GAR in
contrast to SR36-GAR or smaller GAR constructs (data not
shown), suggesting a cis regulation of the GAR domain activity in
SR21-GAR. C) Quantification of Golgi compactness was done by
calculating the percentage of cells with compact Golgi out of all
the total number of transfected cells found on the glass cover slip in
each experiment (SR21-GAR: 5–51 cells, SR21–SR41: 9–41 cells,
mCherry: 22–263 cells, non-transfected (NT): 143–1024 cells).
Data are mean 6 SEM. Student’s t-test, *p = 0.019, **p = 0.004,
n = 3–5 independent experiments.
(TIF)
Figure S8 BPAG1a/b are enriched in the trailing edge of
migrating C2.7 myoblasts. C2.7 cell monolayer (80%
confluent) was wounded, further incubated for 7 h and fixed.
Staining with anti-BPAG1a/b serum reveals stronger signals in the
back than in the front of migrating cells at the wound edge (white
arrows). Black arrow indicates general direction of migration.
Scale bar: 20 mm.
(TIF)
Figure S9 Knockdown of BPAG1 reduces directness of
cell migration in subconfluent C2.7 myoblasts. A) Cells
treated with siRNA, cultivated for 24 h, and reseeded at 5%
confluency. Time lapse photographs were taken of control and
BPAG1 KD myoblasts every 10 min for 19 h. The migratory
paths of individual cells that did not divide are shown from one of
the experiments. B) The mean cell velocities were measured by
manual tracking using ImageJ and pooled from 2 independent
experiments. Cell migration directness was quantified by calculat-
ing Euclidian distance divided by the accumulated distance for
each individual cell (30 cells per siRNA condition). Data are mean
6 SEM (Student’s t-test, n = 2 independent experiments).
(TIF)
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Table S1 Primers used in this study.
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